高级检索
当前位置: 首页 > 详情页

In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ EI

机构: [1]Department of Hepatobiliary and Pancreatic Surgery The 2nd Clinical medical College (Shenzhen People’s Hospital) of Jinan University Shenzhen 518020, China [2]Department of Biomedical Engineering Southern University of Science and Technology Shenzhen 518055, China [3]Integrated Chinese and Western Medicine Postdoctoral research station Jinan University Guangzhou 510632, China [4]Shenzhen Second People’s Hospital The First Affiliated Hospital of Shenzhen University and Key Laboratoryof Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province Shenzhen University Shenzhen 518060, China [5]School of Traditional Chinese Medicine Jinan University Guangzhou 510632, China [6]School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou 510006, China
出处:
ISSN:

关键词: black phosphorus circulating tumor cells EpCAM intravenous catheters photothermal therapy

摘要:
The circulating tumor cell (CTC) count is closely related to cancer recurrence and metastasis. The technology that can in vivo destroy CTCs may bring great benefits to patients, which is an urgent clinical demand. Here, a minimally invasive therapeutic intravenous catheter for in vivo enriching and photothermal killing of CTCs is developed. The surface of catheter is modified with anti-EpCAM antibody and the interior is filled with black phosphorus nanosheets (BPNSs). CTCs in the peripheral blood are captured by the catheter continually with the aid of circulation. The captured CTCs are used for downstream analyses or in vivo eliminated by the near-infrared (NIR) photothermal effect of BPNSs. A capture efficiency of 2.1% is obtained during the 5 min of treatment, and 100% of the captured CTCs are killed by following NIR light irradiation in both an in vitro closed-loop circulation system and an in vivo rabbit model. This cost-effective modality for lowering the CTCs burden can be a good supplement to traditional therapies, which holds great promise as an effective clinical intervention for cancer patients.

基金:

基金编号: 2019YFB2203503 81903131 61875138 81602608 U1801254 2018M643367 KQJSCX20180321164801762 JCYJ20180507181817604 2019A1515110292

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 工程技术
小类 | 1 区 化学综合 1 区 材料科学:综合 1 区 纳米科技
最新[2025]版:
大类 | 1 区 综合性期刊
小类 | 1 区 化学:综合 1 区 材料科学:综合 1 区 纳米科技
JCR分区:
出版当年[2018]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q1 NANOSCIENCE & NANOTECHNOLOGY
最新[2023]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 MATERIALS SCIENCE, MULTIDISCIPLINARY Q1 NANOSCIENCE & NANOTECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Hepatobiliary and Pancreatic Surgery The 2nd Clinical medical College (Shenzhen People’s Hospital) of Jinan University Shenzhen 518020, China [2]Department of Biomedical Engineering Southern University of Science and Technology Shenzhen 518055, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号